EUVIMEDEUVIMED entdecken
Open Access

Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer

Ricardo A Cordova iD, Noah R Sommers iD, Andrew S Law, Angela J Klunk iD, Katherine E Brady iD, David W Goodrich iD, Tracy G Anthony iD, Jeffrey J Brault iD, Roberto Pili, Ronald C Wek iD, Kirk A Staschke iD

Science Signaling · 2024

DOI: 10.1126/scisignal.adp1375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2024. Verfasst von Ricardo A Cordova und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Tumor Suppressor Protein p53, Purines, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancers invoke various pathways to mitigate external and internal stresses to continue their growth and progression. We previously reported that the eIF2 kinase GCN2 and the integrated stress response are constitutively active in prostate cancer (PCa) and are required to maintain amino acid homeostasis needed to fuel tumor growth. However, although loss of GCN2 function reduces intracellular amino acid availability and PCa growth, there is no appreciable cell death. Here, we discovered that the loss of GCN2 in PCa induces prosenescent p53 signaling. This p53 activation occurred through GCN2 inhibition–dependent reductions in purine nucleotides that impaired ribosome biogenesis and, consequently, induced the impaired ribosome biogenesis checkpoint. p53 signaling induced cell cycle arrest and senescence that promoted the survival of GCN2-deficient PCa cells. Depletion of GCN2 combined with loss of p53 or pharmacological inhibition of de novo purine biosynthesis reduced proliferation and enhanced cell death in PCa cell lines, organoids, and xenograft models. Our findings highlight the coordinated interplay between GCN2 and p53 regulation during nutrient stress and provide insight into how they could be targeted in developing new therapeutic strategies for PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsTumor Suppressor Protein p53PurinesProtein Serine-Threonine KinasesSignal TransductionDisease ProgressionMaleHumansAnimalsMiceCell Line, TumorCell Proliferation

Substanzen

Tumor Suppressor Protein p53PurinesProtein Serine-Threonine KinasesEIF2AK4 protein, humanTP53 protein, humanpurine

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, IN 46202, USA.
  • Department of Anatomy, Cell Biology, and Physiology, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
  • Indiana Center for Musculoskeletal Health, Indianapolis, IN 46202, USA.
  • Department of Biology, Indiana University School of Science, Indianapolis, IN 46202, USA.
  • Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14203, USA.

ORCID-Profile: Ricardo A Cordova, Noah R Sommers, Angela J Klunk, Katherine E Brady, David W Goodrich, Tracy G Anthony, Jeffrey J Brault, Ronald C Wek, Kirk A Staschke

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Cordova, R. A., Sommers, N. R., Law, A. S., Klunk, A. J., Brady, K. E., Goodrich, D. W., Anthony, T. G., Brault, J. J., Pili, R., Wek, R. C., & Staschke, K. A. (2024). Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer. Science Signaling. https://doi.org/10.1126/scisignal.adp1375

Vancouver

Cordova RA, Sommers NR, Law AS, Klunk AJ, Brady KE, Goodrich DW, et al. Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer. Science Signaling. 2024. doi:10.1126/scisignal.adp1375

BibTeX
@article{Cordova2024,
  author = {Cordova, Ricardo A and Sommers, Noah R and Law, Andrew S and Klunk, Angela J and Brady, Katherine E and Goodrich, David W and Anthony, Tracy G and Brault, Jeffrey J and Pili, Roberto and Wek, Ronald C and Staschke, Kirk A},
  title = {Coordination between the eIF2 kinase GCN2 and p53 signaling supports purine metabolism and the progression of prostate cancer},
  journal = {Science Signaling},
  year = {2024},
  doi = {10.1126/scisignal.adp1375}
}
Kostenlos starten →